TUMOUR EMBOLISM

This adverse event was reported 192 times

These drugs are most commonly taken by patients reporting TUMOUR EMBOLISM:

# Drug Count
0 CARBOPLATIN 22
1 PEMBROLIZUMAB 21
2 NIVOLUMAB 19
3 SORAFENIB 18
4 PACLITAXEL 17
5 PACLITAXEL (AIBUMIN-BOUND) 14
6 DOCETAXEL 13
7 DOCETAXEL ANHYDROUS 13
8 BEVACIZUMAB 11
9 ATEZOLIZUMAB 10
See all common drugs associated with TUMOUR EMBOLISM

TUMOUR EMBOLISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETHIODIZED OIL 3 0.0023
1 SODIUM FLUORIDE AND POTASSIUM NITRATE 1 0.0010
2 SORAFENIB 18 0.0009
3 ZOLBETUXIMAB 1 0.0007
4 MITOMYCIN 2 0.0005
5 ERIBULIN MESYLATE 2 0.0005
6 REGORAFENIB 6 0.0005
7 FOSINOPIRL SODIUM 1 0.0005
8 DACTINOMYCIN 1 0.0005
9 TRABECTEDIN 1 0.0004
See all drugs enriched for association with TUMOUR EMBOLISM